Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Calvert FormulaDIPSS-Plus (Myelofibrosis)Deauville ScoreEAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2Fleischner 2017 GuidelinesFong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)ISUP Grade GroupsKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022MIPI-b (Biological)MRD Assessment FrameworkMSI/MMR InterpretationMayo 20/2/20 (SMM)NCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0PREDICT v3.0Platinum-Free IntervalR2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSINS ScoreSLiM-CRAB CriteriaSedlis/Peters CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 EligibilityiRECISTiwCLL 2018 ResponsemRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

DiabetologiaJun 8, 2026
Genetics of MASLD: a diabetes perspective

Clinical Context

We think this has broad domain relevance to Lugano Classification (Lymphoma).

British J HaematologyJun 5, 2026
Machine learning‐driven investigation on liquid–liquid phase separation‐related prognostic signature in diffuse large B‐cell lymphoma

Clinical Context

We think this might be relevant to the clinical guidance for Lugano Classification (Lymphoma).

British J HaematologyJun 3, 2026
Cow hooves and clover: Unusual morphology of peripheral T‐cell lymphoma

Clinical Context

We think this might be relevant to the clinical guidance for Lugano Classification (Lymphoma).

Lugano Classification

LUGANOAnn Arbor Lymphoma Staging System

Disease Distribution

Note: Lugano staging integrates anatomic distribution with clinical symptoms (A/B) and extranodal extension (E).

Awaiting Anatomy

The Lugano classification is the clinical standard for staging Hodgkin and non-Hodgkin lymphomas.

Stage Tiers

  • Stage I: Single nodal region
  • Stage II: Multiple regions (same side)
  • Stage III: Nodal regions (both sides)
  • Stage IV: Widespread organs
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Clinical Use

Staging of both Hodgkin and Non-Hodgkin Lymphoma at diagnosis.
Assessing response to therapy (using the Deauville scale).
Determining the need for consolidation radiotherapy in bulky disease.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Deauville Score Interpreter, NCCN-IPI or the FLIPI-2 to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Oncology Tools

Deauville Score Interpreter
NCCN-IPI
FLIPI-2
TNM 8th
mRENAL Score
MSI/MMR Interpretation
TNM 9th Ed
DIPSS-Plus
TNM 9th Ed
Deauville Score
Oncology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.